Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Chi Leung Chiang"'
Autor:
Daniel Sánchez, Shing Fung Lee, Chi Leung Chiang, Irene Oi Ling Wong, Bizu Gelaye, Miguel Angel Luque Fernandez, Denise Shuk Ting Cheung, María José Sánchez
Publikováno v:
Digibug. Repositorio Institucional de la Universidad de Granada
instname
BMJ Open
BMJ Open, Vol 11, Iss 10 (2021)
instname
BMJ Open
BMJ Open, Vol 11, Iss 10 (2021)
MALF was supported by the Spanish National Health Institute Carlos III (Instituto de Salud Carlos III -ISCIII), Miguel Servet--I Investigator Grant/Award Number CP17/00206--EU--FEDER.
Objective We evaluated the temporal trend in gender ratios of
Objective We evaluated the temporal trend in gender ratios of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c364648d7df21ad0870e71eff5cd18e
https://researchonline.lshtm.ac.uk/id/eprint/4663372/7/Lee_etal_2021_Trends-in-gender-of-authors.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4663372/7/Lee_etal_2021_Trends-in-gender-of-authors.pdf
Autor:
S Y Yeung, Ka-On Lam, K S Lau, H C Choi, S F Lee, K K Yuen, Siok-Yee Chan, Chi-Leung Chiang, B Y Chan, TS Choy
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 15:5-13
AIM To investigate treatment patterns and outcomes of metastatic colorectal cancer (mCRC) patients beyond second progression (PD2) since regorafenib and TAS-102 became available in Hong Kong. METHODS The clinical records of consecutive mCRC patients
Autor:
Connie H. M. Ho, Frank Cs. Wong, Kelvin K. K. Ng, Victor Lee, Siu-Ho Chok, W.C. Dai, Cynthia S Y Yeung, Chi-Leung Chiang, To-Wai Leung, Albert Cy Chan, Tan To Cheung, T Wong, Mai-Yee Luk, Chung Mau Lo, Ann-Shing Lee
Publikováno v:
Surgical Oncology. 28:228-235
Background This study compared outcomes of nonresectable hepatocellular carcinoma (HCC) who had transarterial chemoembolization (TACE) vs. stereotactic body radiation therapy (SBRT) after TACE (TACE + SBRT). Methods This was a retrospective study of
Autor:
Ren Ji, Kelvin K. Ng, Wenqi Chen, Weihong Yang, Hongtao Zhu, Tan-To Cheung, Chi-Leung Chiang, Tiffany C.L. Wong, Feng-Ming Kong, G. Wu, Chung-Mau Lo
Publikováno v:
Medicine
Stereotactic body radiotherapy (SBRT) is a novel noninvasive treatment for unresectable hepatocellular carcinoma (HCC). Whether its efficacy is comparable to radiofrequency ablation (RFA), a recommended therapy for unresectable HCC, is unknown. The p
Autor:
Venus W Y Lee, Cynthia S Y Yeung, Kam Sze Tsang, Natalie S. M. Wong, Connie H. M. Ho, S. K. Ha, Mark ka heng Chan, Francis A. S. Lee, Chi-Leung Chiang, B. Wang
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific Reports
This study aims at evaluating the symptom response, response duration, and toxicity of single dose palliative liver radiotherapy (RT) for symptomatic HCC patients. We reviewed unresectable HCC patients treated with palliative RT in our institution. E
Autor:
Conrad Lee, Kwong Chuen Leung, Marc K. C. Chong, Steward Tung, Jacques Jolivet, Francis A. S. Lee, Maria Lai, Chi-Leung Chiang, Chloe Kwok, Philip W.K. Kwong, Steven Kin-Lok Siu, FY Cheung, Benny Zee
Publikováno v:
American Journal of Clinical Oncology. 39:609-613
Objectives This multicenter, randomized, open-label, phase II trial evaluated the efficacy and safety of AEG35156 in addition to sorafenib in patients with advanced hepatocellular carcinoma (HCC), as compared with sorafenib alone. Methods Eligible pa
Publikováno v:
Prostate cancer and prostatic diseases. 23(1)
Several randomized control trials (RCTs) have showed that adding either abiraterone acetate (AA) or docetaxel (D) to androgen-deprivation therapy (ADT) improves survival of metastatic castration-sensitive prostate cancer patients (mCSPC). Yet, the co
Autor:
Jessica W.Y. Lai, Darren M.C. Poon, James C.H. Chow, Horace C.W. Choi, Wai Tong Ng, Tin‐Ching Chau, Kwok-Hung Au, Anthony H.P. Tam, Victor Ho-Fun Lee, Chi-Leung Chiang, Edwin C.Y. Wong, Anne W.M. Lee, Alice K.W. Cheung
Publikováno v:
HeadneckREFERENCES. 41(10)
Background This study evaluates the contemporary care for patients with locally recurrent nasopharyngeal carcinoma after failure of the primary course of intensity modulated radiotherapy. Methods Eligible patients were identified through the Hong Kon
Publikováno v:
JAMA Network Open
Key Points Question Is pembrolizumab a cost-effective second-line therapy for advanced hepatocellular carcinoma from the US perspective? Findings In this economic evaluation of data from the KEYNOTE-240 randomized trial, the incremental number of qua
Autor:
Wai Tong Ng, Jessica W.Y. Lai, Edwin C.Y. Wong, Anne W.M. Lee, James C.H. Chow, Kwok-Hung Au, Victor Ho-Fun Lee, Sunny P.C. Chan, Roger Kai Cheong Ngan, Macy Tong, Alice K.W. Cheung, Anthony H.P. Tam, K.M. Cheung, Chi-Leung Chiang
Publikováno v:
Oral Oncology. 111:105012
Objectives Long-term risk of second primary cancer (SPC) after definitive intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC) remains unclear. This study aims to evaluate the risk, predictive factors and survival impact of SPC